Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Bruce Jancin

    News

    Delusional infestation surges during COVID-19 pandemic

    Author:
    Bruce Jancin
    Publish date: February 4, 2021

    Experts weigh in on management of this challenging disorder marked by tenacious false beliefs.

    • Read More

    News

    Adalimumab enhances primary wound closure after HS surgery

    Author:
    Bruce Jancin
    Publish date: February 2, 2021

    Primary wound closure following surgery for HS is controversial.

    • Read More

    News

    Hypochlorous acid is a valuable adjunctive treatment in AD

    Author:
    Bruce Jancin
    Publish date: February 2, 2021

    Stabilized topical hypochlorous acid has potent antimicrobial and antipruritic effects.

    • Read More

    News

    Topical brepocitinib for atopic dermatitis meets endpoints in phase 2b study

    Author:
    Bruce Jancin
    Publish date: January 29, 2021

    First-in-class inhibitor of tyrosine kinase 2 and Janus kinase 1 scores for mild-to-moderate AD.

    • Read More

    News

    Expert highlights advances in DRESS

    Author:
    Bruce Jancin
    Publish date: January 28, 2021

    Recent data demonstrate that DRESS symptoms often occur within just a week or two of drug exposures.

    • Read More

    News

    Oral JAK1 inhibitor shows promise for hidradenitis suppurativa

    Author:
    Bruce Jancin
    Publish date: January 26, 2021

    Favorable safety and efficacy shown in phase 2, proof-of-concept studies.

    • Read More

    News

    Guselkumab maintains psoriasis efficacy long after discontinuation

    Author:
    Bruce Jancin
    Publish date: January 26, 2021

    A potential flexible dosing indication for the IL-23 inhibitor is under study.

    • Read More

    News

    Dermatologist survey spotlights psoriasis care deficiencies in reproductive-age women

    Author:
    Bruce Jancin
    Publish date: January 22, 2021

    Study suggests dermatologists’ shared decision-making skills need sharpening.

    • Read More

    News

    Expert panel addresses gaps in acne guidelines

    Author:
    Bruce Jancin
    Publish date: January 22, 2021

    Current acne guidelines fall short regarding long-term maintenance therapy and patient-centered care, experts say.

    • Read More

    News

    Patients dislike prurigo nodularis treatment options, survey finds

    Author:
    Bruce Jancin
    Publish date: January 21, 2021

    Nearly 30% in European patient survey say no available treatments are effective.

    • Read More

    News

    Face masks can aggravate rosacea

    Author:
    Bruce Jancin
    Publish date: January 20, 2021

    The mask-aggravated rosacea, or “maskacea,” was mainly localized to the dorsal lower third of the nose as well as the cheeks.

    • Read More

    News

    Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma

    Author:
    Bruce Jancin
    Publish date: January 14, 2021

    Results of German IMMUNED trial turn heads in advanced melanoma field.

    • Read More

    News

    Deucravacitinib offers biologic-like psoriasis efficacy in oral form

    Author:
    Bruce Jancin
    Publish date: January 8, 2021

    Novel anti-inflammatory mechanism involves selective TYK2 inhibition.

    • Read More

    News

    Expert offers clinical pearls on leg ulcer therapy

    Author:
    Bruce Jancin
    Publish date: January 7, 2021

    “If no contraindications exist, compression therapy is the best antihypertensive and anti-inflammatory treatment for all leg ulcers, not only...

    • Read More

    News

    Telltale dermoscopic features of melanomas lacking pigment reviewed

    Author:
    Bruce Jancin
    Publish date: January 6, 2021

    Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery